Evaluation and Management of a Nodule Near Venous Catheter Insertion Site
Remove the catheter immediately if there is pain, induration, erythema, or exudate at the insertion site, and culture any drainage 1.
Initial Assessment
When you encounter a bump-like nodule near a venous catheter insertion site, your first priority is determining whether this represents:
- Superficial phlebitis (most common with peripheral catheters)
- Catheter-related bloodstream infection (CRBSI) with local manifestations
- Suppurative thrombophlebitis
- Fungal infection (particularly in immunocompromised patients)
Critical Clinical Findings
Examine the site for:
- Pain or tenderness at the nodule
- Erythema extending beyond the immediate insertion site
- Induration or cord-like thickening along the vein
- Purulent drainage or exudate
- Warmth compared to surrounding tissue
Check for systemic signs:
- Fever or unexplained temperature elevation
- Sepsis or hemodynamic instability
- New positive blood cultures
Management Algorithm
For Peripheral Venous Catheters
Immediate catheter removal is mandatory if any of the following are present 1:
- Pain at the insertion site
- Induration
- Erythema
- Any exudate
After removal, culture any drainage using Gram stain and routine bacterial culture. In immunocompromised patients, also send for fungal and acid-fast organism cultures 1.
For Central Venous Catheters (Non-tunneled)
The decision tree is more nuanced:
Remove the catheter immediately if 1:
- Purulence at the insertion site
- Erythema overlying the catheter site
- Unexplained sepsis
- Positive blood cultures with catheter tip showing significant growth
Consider catheter retention with blood culture surveillance if:
- New fever without severe sepsis
- No visible purulence or erythema
- Hemodynamically stable
Obtain blood cultures from both the catheter and a peripheral vein before initiating antibiotics 1.
Special Considerations
Immunocompromised Patients
This population requires heightened vigilance. The nodule could represent disseminated fungal infection, particularly:
Candida species: Present as discrete pink-to-red papules (0.5-1.0 cm), usually non-tender, on trunk and extremities. Up to 13% of patients with invasive candidiasis develop these skin lesions 2.
Aspergillus, Rhizopus, or Mucor: Cause painful erythematous nodules that become necrotic, resembling ecthyma gangrenosum due to angioinvasion 2.
Fusarium species: Present with multiple erythematous macules with central pallor evolving to necrotic nodules, preferentially on extremities 2.
For immunocompromised patients with a nodule near catheter sites, immediately consult dermatology and consider biopsy with surgical debridement 2. Send tissue for fungal, bacterial, and mycobacterial cultures.
Common Pitfalls
Do not rely on site appearance alone to rule out infection. Local inflammation is uncommon even with infected catheters, particularly when caused by coagulase-negative staphylococci (the most common pathogen). The sensitivity of local inflammation for diagnosing CRBSI is only 0-3% 3.
Do not assume a single positive blood culture for coagulase-negative Staphylococcus represents true infection. Obtain additional cultures from both the catheter and peripheral vein before removing the catheter or starting antibiotics 1.
Do not use thrombolytic agents (like urokinase) as adjunctive treatment for catheter-related infections 1.
Antibiotic Considerations
If systemic infection is suspected and the catheter is removed, initiate empiric antibiotics covering:
- Methicillin-resistant coagulase-negative staphylococci (most common)
- MRSA (if risk factors present)
- Gram-negative organisms (depending on clinical severity)
Vancomycin is standard empiric therapy, but note that efficacy decreases if the MRSA MIC is ≥2 μg/mL 1.
Duration of therapy depends on whether the infection is complicated (with suppurative thrombophlebitis, endocarditis, or metastatic seeding) versus uncomplicated 1.